10 COVID-19-related research findings 

Here are 10 COVID-19-related studies Becker’s has covered since July 18: 

Advertisement

1. One in 8 patients recovering from COVID-19 had lingering symptoms from the illness at least three months later, a study published Aug. 6 in The Lancet found. 

2. Children and adolescents aged 0-17 years recovering from COVID-19 have experienced a variety of “uncommon or rare” conditions for the age demographic, the CDC’s “Morbidity and Mortality Weekly Report” for Aug. 5 found.

3. Rebounding COVID-19 symptoms may occur in nearly one-third of people infected with the virus, even if they haven’t taken Paxlovid, early research suggests. 

4. Ramping up COVID-19 booster administration this fall could save up to 160,000 lives and prevent more than 1 million hospitalizations, according to a July 26 analysis from the Commonwealth Fund.

5. The list of long COVID-19 symptoms may be much longer than the 20 included in the World Health Organization’s clinical case definition of the condition, according to a study published July 25 in Nature Medicine. 

6. The top symptoms of COVID-19 from the omicron variant, a sore throat and hoarse voice, differ from common symptoms from other variants.

7. A new study involving more than 428,000 COVID-19 patients found the infection is tied to a sixfold increase in heart disease diagnoses in the weeks after infection, compared to those without COVID-19. 

8. Fully vaccinated patients who undergo surgery soon after COVID-19 don’t have an elevated risk of post-surgery complications compared to surgery patients with no COVID-19 history, according to a study published July 15 in Annals of Surgery. 

9. COVID-19 reinfections are becoming more common in the U.S., but they are not happening more quickly, according to data from Helix, a lab that works with the CDC on viral surveillance. 

10. COVID-19 vaccines were more effective during the winter omicron surge, when BA.1 accounted for most cases, than they were this spring, when BA.2/BA.2.12.1 prevailed, according to a CDC study.  

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Public Health

Advertisement

Comments are closed.